Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 32

Trial Status

Completed1
Terminated2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT01875874Phase 2Terminated
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-Function+1 more
Principalinvestigator

Research Network

Collaboration Network

82 collaborators·123 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Talal Adhami, MD

OH - Cleveland Clinic Foundation

Very Similar
4 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+3 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 3 trials
Similarity Score72%

Ram Subramanian, MD

GA - Emory University Hospital

Very Similar
4 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+3 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 3 trials
Similarity Score72%

Kalyan R Bhamidimarri, MD

FL - University of Miami Hospital

Very Similar
3 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+3 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 3 trials
Similarity Score72%

Rohit Satoskar, MD

DC - Georgetown University Hospital

Very Similar
3 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+3 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 3 trials
Similarity Score72%

Lance Stein, MD

GA - Piedmont Atlanta Hospital

Similar
3 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+3 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score68%

Angel Alsina, MD

FL - Tampa General Hospital

Similar
2 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

David J Reich, MD

PA - Drexel University College of Medicine

Similar
2 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

Nikolaos T Pyrsopoulos, MD

NJ - Rutgers University Hospital

Similar
2 trials

Shared therapeutic areas:

Liver Failure, AcuteLiver Failure, FulminantPrimary Graft Non-Function+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

Paul J Gaglio, MD

NY - Montefiore Medical Center

Similar
2 trials

Shared therapeutic areas:

Liver Failure, AcuteLiver Failure, FulminantPrimary Graft Non-Function+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

Xaralambos Zervos, DO

FL - Cleveland Clinic Florida

Similar
2 trials

Shared therapeutic areas:

Liver Failure, AcuteLiver Failure, FulminantPrimary Graft Non-Function+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01471028Phase 3PrincipalInvestigator

Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure

Acute Alcoholic Hepatitis
Completed
NCT01829347Phase 3PrincipalInvestigator

To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure

Severe Acute Alcoholic Hepatitis
Terminated
NCT01875874Phase 2PrincipalInvestigator

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-Function+1 more
Terminated

All 3 trials loaded